These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16173925)

  • 1. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
    Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors.
    Tambaro S; Mongeau R; Dessi C; Pani L; Ruiu S
    Eur J Pharmacol; 2005 Nov; 525(1-3):150-3. PubMed ID: 16271359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH; Oriowo MA
    Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.
    Guagnini F; Valenti M; Mukenge S; Matias I; Bianchetti A; Di Palo S; Ferla G; Di Marzo V; Croci T
    Gut; 2006 Jul; 55(7):946-53. PubMed ID: 16423891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
    Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA
    Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
    Nilsson O; Fowler CJ; Jacobsson SO
    Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.
    Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
    Int Arch Allergy Immunol; 2005 Sep; 138(1):80-7. PubMed ID: 16103691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AM630, a competitive cannabinoid receptor antagonist.
    Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
    Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.
    Croci T; Manara L; Aureggi G; Guagnini F; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Dec; 125(7):1393-5. PubMed ID: 9884065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.